SLC5A2 and diabetic kidney disease: 27 DeFronzo DeFronzo RA RA Reeves Reeves WB WB Awad Awad AS AS Pathophysiology of Diabetic Kidney Disease: Impact of SGLT2 Inhibitors Pathophysiology of Diabetic Kidney Disease: Impact of SGLT2 Inhibitors Nat Rev Nephrol Nat Rev Nephrol 2021 2021 17 17 5 5 319 319 334 334 10.1038/s41581-021-00393-8 10.1038/s41581-021-00393-8 33547417 33547417